1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of UGT2B mRNA CTD PMID:25380136 , PMID:30723492 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of UGT2B mRNA CTD PMID:17108234 2,3,4,7,8-Pentachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:16984957 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGT2B mRNA CTD PMID:19692669 , PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of UGT2B4 mRNA CTD PMID:20558275 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:19692669 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:30744511 3,4,5,3',4',5'-Hexachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:30744511 3alpha-hydroxy-5beta-androstan-17-one increases glucuronidation EXP 6480464 UGT2B protein results in increased glucuronidation of Etiocholanolone CTD PMID:2429951 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1 more ... CTD PMID:19162173 , PMID:19695238 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of UGT2B mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of UGT2B mRNA CTD PMID:30723492 9-cis-retinoic acid decreases expression EXP 6480464 Alitretinoin results in decreased expression of UGT2B mRNA CTD PMID:16648578 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of UGT2B mRNA CTD PMID:31881176 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of UGT2B mRNA CTD PMID:24977338 alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of UGT2B mRNA CTD PMID:16940010 androsterone increases glucuronidation EXP 6480464 UGT2B protein results in increased glucuronidation of Androsterone CTD PMID:2429951 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of UGT2B mRNA CTD PMID:20607812 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of UGT2B mRNA CTD PMID:16648578 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of UGT2B mRNA, bisphenol A results in decreased expression of UGT2B4 mRNA CTD PMID:25181051 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of UGT2B mRNA CTD PMID:30903817 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of UGT2B mRNA CTD PMID:20607812 coumarin decreases expression EXP 6480464 coumarin results in decreased expression of UGT2B mRNA CTD PMID:18480146 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of UGT2B mRNA CTD PMID:23640034 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of UGT2B mRNA CTD PMID:23914054 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of UGT2B mRNA CTD PMID:20607812 Diallyl sulfide increases expression EXP 6480464 allyl sulfide results in increased expression of UGT2B4 mRNA CTD PMID:19695238 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of UGT2B4 mRNA CTD PMID:15345336 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of UGT2B mRNA CTD PMID:21396975 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of UGT2B mRNA CTD PMID:18299717 lithocholic acid increases glucuronidation EXP 6480464 UGT2B protein results in increased glucuronidation of Lithocholic Acid CTD PMID:2429951 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of UGT2B mRNA CTD PMID:25380136 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of UGT2B mRNA CTD PMID:16221955 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of UGT2B mRNA CTD PMID:16940010 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of UGT2B mRNA CTD PMID:19162173 propranolol increases glucuronidation EXP 6480464 UGT2B protein results in increased glucuronidation of Propranolol CTD PMID:15801678 tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of UGT2B mRNA CTD PMID:15885361 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of UGT2B mRNA CTD PMID:16239168 troglitazone increases glucuronidation EXP 6480464 UGT2B protein results in increased glucuronidation of troglitazone CTD PMID:11201174 vitamin E decreases expression EXP 6480464 Vitamin E results in decreased expression of UGT2B4 mRNA CTD PMID:28923436 zearalenone increases expression EXP 6480464 Zearalenone results in increased expression of UGT2B mRNA CTD PMID:20607812 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of UGT2B mRNA CTD PMID:12672911 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of UGT2B mRNA CTD PMID:12672911